Different Trypanosoma cruzi calreticulin domains mediate migration and proliferation of fibroblasts in vitro and skin wound healing in vivo
- 140 Downloads
Calreticulin is an endoplasmic reticulum-resident, calcium-binding, stress-produced, chaperone protein that serves multiple functions and is widely distributed in eukaryotic cells. Exogenously applied recombinant calreticulin solution, markedly enhanced the rate and quality of skin wound healing. These modulatory effects are more efficient than commercially available topic platelet-derived growth factor ointments (Regranex®). Trypanosoma cruzi calreticulin is more effective in equimolar terms to human counterpart in accelerating skin wound healing. While the effect of externally added recombinant parasite calreticulin on wound healing has been reported, the domains responsible for these modulatory effects have not yet been established. Here, recombinant parasite calreticulin and some of its domains were tested to assess their influence in increasing proliferation and migration of fibroblasts in vitro and rat skin wound healing in vivo. Herein, we propose that Trypanosoma cruzi whole calreticulin or some of its domains are differentially involved in the modulation of wound-healing cell migration and proliferation, and cosmetic outcome. Therefore, precise combination of the parasite protein and its domains could allow us to tailor-specific desired effects during the skin wound-healing process.
KeywordsTrypanosoma cruzi Calreticulin Domains Proliferation Migration Skin wound healing
Research in the author’s laboratory was supported by the FONDECYT 11130257 Grant of CONICYT Chile. We thank Dr. David Carrino for his helpful suggestions in the preparation of this manuscript.
Compliance with ethical standards
Research involving human and animal rights
All animal procedures were approved by the local Animal Bioethics Committee in accordance with the International Guiding Principles for Biomedical Research Involving Animals, were developed by the Council for International Organizations of Medical Sciences (CIOMS), and were supervised by trained veterinary medical staff.
- 16.Game FL, Apelqvist J, Attinger C, Hartemann A, Hinchliffe RJ, Löndahl M, Price PE, Jeffcoate WJ, On behalf of the International Working Group on the Diabetic Foot (IWGDF) (2016) Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev 32:154–168CrossRefPubMedGoogle Scholar
- 19.Gold LI, Rahman M, Blechman KM, Greives MR, Churgin S, Michaels J, Callaghan MJ, Cardwell NL, Pollins AC, Michalak M, Siebert JW, Levine JP, Gurtner GC, Nanney LB, Galiano RD, Cadacio CL (2006) Overview of the role for calreticulin in the enhancement of wound healing through multiple biological effects. J Investig Dermatol Symp Proc 11:57–65CrossRefPubMedGoogle Scholar
- 39.Persson U, Willis M, Odegaard K, Apelqvist J (2002) The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data. Value Health 3(Suppl 1):39–46Google Scholar
- 42.Rajkumar VS, Shiwen X, Bostrom M, Leoni P, Muddle J, Ivarsson M, Gerdin B, Denton CP, Bou-Gharios G, Black CM, Abraham DJ (2006) Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 169:2254–2265CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Ramirez G, Valck C, Molina MC, Ribeiro CH, Lopez N, Sanchez G, Ferreira VP, Billetta R, Aguilar L, Maldonado I, Cattan P, Schwaeble W, Ferreira A (2011) Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Immunobiology 216:265–273CrossRefPubMedGoogle Scholar
- 47.Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M (2005) Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167:59–69CrossRefPubMedPubMedCentralGoogle Scholar